TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | 8 | 11 | 2 | 9 | 1 | 5 |
| P | %wins | 100 | 100 | 100 | 50 | 50 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/25/17 12:11 | 8/24/17 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Kraeutler John A | OH | DO | CB,CEO | P | 96 | 13.67 | 0 | 7 | 2 | 346 | D | ||||||||||||||
11/7/16 12:52 | 11/4/16 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Kraeutler John A | OH | DO | CB,CEO | P | 81 | 16.13 | 5 | 5 | 2 | 317 | D | -6 | -16 | -15 | -17 | -18 | -13 | -4 | -1 | 1 | 8 | 12 | -20 | -7 | |
5/3/13 10:52 | 5/1/13 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Kraeutler John A | OH | DO | CEO | P | 98 | 19.63 | 4 | 5 | 2 | 226 | D | -12 | 3 | 4 | -3 | -10 | -8 | -7 | 2 | 4 | 7 | 9 | 24 | 25 | 1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |